posted on 2007-11-13, 00:00authored byMelisa M. Cherney, Samuel Pazicni, Nina Frank, Katherine A. Marvin, Jan P. Kraus, Judith N. Burstyn
Cystathionine β-synthase (CBS) is a pyridoxal-5‘-phosphate-dependent enzyme that catalyzes
the condensation of serine and homocysteine to form cystathionine. Mammalian CBS also contains a
heme cofactor that has been proposed to allosterically regulate enzyme activity via the heme redox state,
with FeII CBS displaying approximately half the activity of FeIII CBS in vitro. The results of this study
show that human FeII CBS spontaneously loses enzyme activity over the course of a 20 min enzyme
assay. Both the full-length 63-kDa and truncated 45-kDa form of CBS slowly and irreversibly lose activity
upon reduction to the FeII form. Additionally, electronic absorption spectroscopy reveals that FeII CBS
undergoes a heme ligand exchange to FeII CBS424 when the enzyme is incubated at 37 °C and pH 8.6.
The addition of enzyme substrates or imidazole has a moderate effect on the rate of the ligand switch, but
does not prevent conversion to the inactive species. Time-dependent spectroscopic data describing the
conversion of FeII CBS to FeII CBS424 were fitted to a three-state kinetic model. The resultant rate constants
were used to fit assay data and to estimate the activity of FeII CBS prior to the ligand switch. Based on
this fit it appears that FeII CBS initially has the same enzyme activity as FeIII CBS, but FeII CBS loses
activity as the ligand switch proceeds. The slow and irreversible loss of FeII CBS enzyme activity in vitro
resembles protein denaturation, and suggests that a simple regulatory mechanism based on the heme redox
state is unlikely.